// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Single versus (vs) double chest tube drainage following lobectomy;do we still need to debate this or is it a ‘no brainer’?

Georgia Hardavella - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Video-assisted thoracoscopic surgery lobectomy: which patients require postoperative physiotherapy?

Paula Agostini - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

The role of lymphopenia in the development and severity of postoperative pulmonary complications after lung surgery

Sebastian Lugg - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Lymphocytopenia

N/A

A bibliometric overview of e-cigarette publications from 2007 to 2016

Filippos T. Filippidis - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Quitting smoking following a diagnosis of lung cancer from the perspectives of patents and professionals

Rachel Gemine - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Are severe asthmatics still smoking?

Paraskevi Katsaounou - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Trends in exposure to secondhand smoke in the European Union, 2009-2014

Filippos T. Filippidis - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Smoking prevalence in UK hospital admissions from a national observational study

Zaheer Mangera - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Smoking Cessation in Europe: Trends in methods used in the European Union between 2012 and 2014

Constantine Vardavas - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Temporal trends in smoking cessation in Europe from 1980 to 2010

Giancarlo Pesce - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Post hoc analysis of a randomized trial of azithromycin in bronchiolitis obliterans syndrome after Lung transplantation (BOS); Lung function and survival

Tji Gan - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Obliterative bronchiolitis

Azithromycin

Video observed treatment for tuberculosis patients in Belarus

Alena Skrahina - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

The utility of EBUS-TBNA in the investigation of suspected mediastinal and hilar tuberculosis in children

Haider Al-Najjar - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Review of Tuberculosis outbreak in a Boarding School in Bolton, United Kingdom

Rizwan Ahmed - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Opportunistic screening for Tuberculosis in homeless patients

Campbell Pamela - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

Interferon Gamma

Impact of enhanced case finding on case notification rate in pulmonary tuberculosis

Ashish Kumar Prakash - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Are TB services in England adhering to new NICE guidelines on screening for latent TB?

Christopher Craig - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Retrospective Cohort Study over a period of 5 years of Spinal Tuberculosis at a large London Tertiary Centre

Yunshu Ma - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Tb or not Tb; that is the paradoxical reaction

Aqsa Haq - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prevalence and factors associated with the Tuberculosis (TB) and Diabetes (DM) co-occurrence: a cross sectional study from Sri Lanka

Amila Rathnapala - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Tuberculosis

N/A

Copyright © 2026. QuantiNova All rights reserved